A	a	O	O
case	case	O	O
of	of	O	O
tardive	tardive	O	B_disease
dyskinesia	dyskinesia	O	S_disease
caused	caused	O	O
by	by	O	O
metoclopramide	metoclopramide	S_chemicals	O
.	.	O	O

Abnormal	abnormal	O	O
involuntary	involuntary	O	B_disease
movements	movements	O	I_disease
appeared	appeared	O	O
in	in	O	O
the	the	O	O
mouth	mouth	O	O
,	,	O	O
tongue	tongue	O	O
,	,	O	O
neck	neck	O	O
and	and	O	O
abdomen	abdomen	O	O
of	of	O	O
a	a	O	O
64-year-old	64-year-old	O	O
male	male	O	O
patient	patient	O	O
after	after	O	O
he	he	O	O
took	took	O	O
metoclopramide	metoclopramide	S_chemicals	O
for	for	O	O
gastrointestinal	gastrointestinal	O	B_disease
disorder	disorder	O	I_disease
in	in	O	O
a	a	O	O
regimen	regimen	O	O
of	of	O	O
30	30	O	O
mg	mg	O	O
per	per	O	O
day	day	O	O
for	for	O	O
a	a	O	O
total	total	O	O
of	of	O	O
about	about	O	O
260	260	O	O
days	days	O	O
.	.	O	O

The	the	O	O
symptoms	symptoms	O	O
exacerbated	exacerbated	O	O
to	to	O	O
a	a	O	O
maximum	maximum	O	O
in	in	O	O
a	a	O	O
month	month	O	O
.	.	O	O

When	when	O	O
the	the	O	O
metoclopramide	metoclopramide	S_chemicals	O
administration	administration	O	O
was	was	O	O
discontinued	discontinued	O	O
,	,	O	O
the	the	O	O
abnormal	abnormal	O	B_disease
movements	movements	O	I_disease
gradually	gradually	O	O
improved	improved	O	O
to	to	O	O
a	a	O	O
considerable	considerable	O	O
extent	extent	O	O
.	.	O	O

Attention	attention	O	O
to	to	O	O
the	the	O	O
possible	possible	O	O
induction	induction	O	O
of	of	O	O
specific	specific	O	O
tardive	tardive	O	B_disease
dyskinesia	dyskinesia	O	S_disease
is	is	O	O
called	called	O	O
for	for	O	O
in	in	O	O
the	the	O	O
use	use	O	O
of	of	O	O
this	this	O	O
drug	drug	S_chemicals	O
.	.	O	O

